Intermittent hypoxia-induced glucose intolerance is abolished by a-adrenergic blockade or adrenal medullectomy

American Journal of Physiology - Endocrinology and Metabolism

Volumn 307, Issue 11, 2014, Pages E1073-E1083

  Jun, Jonathan C ^a   Shin, Mi Kyung ^a   Devera, Ronald ^a   Yao, Qiaoling ^a   Mesarwi, Omar ^a   Bevans Fonti, Shannon ^a   Polotsky, Vsevolod Y ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Sympathetic; Thermoneutral

Indexed keywords

FATTY ACID; GLUCOSE; GLYCEROL; INSULIN; LACTIC ACID; PHENTOLAMINE; PROPRANOLOL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADRENAL MEDULLECTOMY; ALPHA ADRENERGIC RECEPTOR BLOCKING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; GLYCOGENOLYSIS; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; INTERMITTENT HYPOXIA; LIPOLYSIS; MALE; MOUSE; NONHUMAN; OXYGEN DESATURATION; SLEEP DISORDERED BREATHING; ADRENAL MEDULLA; ADRENERGIC SYSTEM; ANIMAL; ANOXIA; C57BL MOUSE; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADRENAL MEDULLA; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ANOXIA; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE INTOLERANCE; MALE; MICE; MICE, INBRED C57BL; OXYGEN CONSUMPTION; SLEEP APNEA, OBSTRUCTIVE; SYMPATHETIC NERVOUS SYSTEM;

EID: 84913525566     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00373.2014     Document Type: Article

References (78)

1. Ahlquist RP. Development of the concept of alpha and beta adrenotropic receptors. Ann NY Acad Sci 139: 549–552, 1967.
2. Allison SP, Chamberlain MJ, Miller JE, Ferguson R, Gillett AP, Bemand BV, Saunders RA. Effects of propranolol on blood sugar, insulin and free fatty acids. Diabetologia 5: 339–342, 1969.
3. Aronsohn RS, Whitmore H, Van CE, Tasali E. Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am J Respir Crit Care Med 181: 507–513, 2010.
4. Babu AR, Herdegen J, Fogelfeld L, Shott S, Mazzone T. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 165: 447–452, 2005.
5. Barth E, Albuszies G, Baumgart K, Matejovic M, Wachter U, Vogt J, Radermacher P, Calzia E. Glucose metabolism and catecholamines. Crit Care Med 35: S508–S518, 2007.
6. Baum D. Inhibition of lipolysis by hypoxia in puppies. Proc Soc Exp Biol Med 125: 1190–1194, 1967.
7. Baum D. The inhibition of norepinephrine-stimulated lipolysis by acute hypoxia. J Pharmacol Exp Ther 169: 87–94, 1969.
8. Baum D, Porte D Jr. Beta adrenergic receptor dysfunction in hypoxic inhibition of insulin release. Endocrinology 98: 359–366, 1976.
9. Baum D, Porte D Jr. Stress hyperglycemia and the adrenergic regulation of pancreatic hormones in hypoxia. Metabolism 29: 1176–1185, 1980.
10. Bialasiewicz P, Czupryniak L, Pawlowski M, Nowak D. Sleep disordered breathing in REM sleep reverses the downward trend in glucose concentration. Sleep Med 12: 76–82, 2011.
11. Boden G. Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver. Curr Diab Rep 6: 177–181, 2006.
12. Botros N, Concato J, Mohsenin V, Selim B, Doctor K, Yaggi HK. Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med 122: 1122–1127, 2009.
13. Brisson GR, Malaisse-Lagae F, Malaisse WJ. Effect of phentolamine upon insulin secretion during exercise. Diabetologia 7: 223–226, 1971.
14. Brotman DJ, Girod JP. The metabolic syndrome: a tug-of-war with no winner. Cleve Clin J Med 69: 990–994, 2002.
15. Cannon B, Nedergaard J. Nonshivering thermogenesis and its adequate measurement in metabolic studies. J Exp Med 214: 242–253, 2011.
16. Celen YT, Hedner J, Carlson J, Peker Y. Impact of gender on incident diabetes mellitus in obstructive sleep apnea: a 16-year follow-up. J Clin Sleep Med 6: 244–250, 2010.
17. Czupryniak L, Loba J, Pawlowski M, Nowak D, Bialasiewicz P. Treatment with continuous positive airway pressure may affect blood glucose levels in nondiabetic patients with obstructive sleep apnea syndrome. Sleep 28: 601–603, 2005.
18. Dawson A, Abel SL, Loving RT, Dailey G, Shadan FF, Cronin JW, Kripke DF, Kline LE. CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep. J Clin Sleep Med 4: 538–542, 2008.
19. Deibert DC, Defronzo RA. Epinephrine-induced insulin resistance in man. J Clin Invest 65: 717–721, 1980.
20. Dick TE, Hsieh YH, Wang N, Prabhakar N. Acute intermittent hypoxia increases both phrenic and sympathetic nerve activities in the rat. Exp Physiol 92: 87–97, 2007.
21. Drager LF, Li J, Reinke C, Bevans-Fonti S, Jun JC, Polotsky VY. Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity. Obesity (Silver Spring) 19: 2167–2174, 2011.
22. Elizur A, Maliar A, Shpirer I, Buchs AE, Shiloah E, Rapoport MJ. Decreased nocturnal glucose variability in non-diabetic patients with sleep apnea: a pilot study. Israel Med Assoc J 15: 465–469, 2013.
23. Fabian HE, Chemerinski E, Merlo AB, Izquierdo JA. Effect of pro-pranolol on free fatty acids of mice plasma during a passive avoidance test. Psychopharmacologia 30: 369–374, 1973.
24. Fagerholm V, Haaparanta M, Scheinin M. alpha2-adrenoceptor regulation of blood glucose homeostasis. Basic Clin Pharmacol Toxicol 108: 365–370, 2011.
25. Frayn KN. Fat as a fuel: emerging understanding of the adipose tissue-skeletal muscle axis. Acta Physiol (Oxf) 199: 509–518, 2010.
26. Gimeno-Orna JA, Castro-Alonso FJ, Boned-Juliani B, Lou-Arnal LM. Fasting plasma glucose variability as a risk factor of retinopathy in type 2 diabetic patients. J Diabetes Comp 17: 78–81, 2003.
27. Haffner CA, Kendall MJ. Metabolic effects of beta 2-agonists. J Clin Pharm Ther 17: 155–164, 1992.
28. Hall PE, Smith SR, Jack DB, Kendall MJ. The influence of beta-adrenoceptor blockade on the lipolytic response to exercise. J Clin Pharm Ther 12: 101–106, 1987.
29. Harsch IA, Schahin SP, Radespiel-Troger M, Weintz O, Jahreiss H, Fuchs FS, Wiest GH, Hahn EG, Lohmann T, Konturek PC, Ficker JH. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 169: 156–162, 2004.
30. Hermansen K, Hyttel I. The hyperglycaemic activity of some cat-echolamines and the effect of alph- and beta-adrenergic blocking compounds in the mouse. Acta Pharmacol Toxicol 29: 87–94, 1971.
31. Hill J. The oxygen consumption of new-born and adult mammals. Its dependence on the oxygen tension in the inspired air and on the environmental temperature. J Physiol 149: 346–373, 1959.
32. Iftikhar IH, Khan MF, Das A, Magalang UJ. Meta-analysis: continuous positive airway pressure improves insulin resistance in patients with sleep apnea without diabetes. Ann Am Thoracic Soc 10: 115–120, 2013.
33. Iiyori N, Alonso LC, Li J, Sanders MH, Garcia-Ocana A, O’Doherty RM, Polotsky VY, O’Donnell CP. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med 175: 851–857, 2007.
34. Jackson BT, Cohn HE, Morrison SH, Baker RM, Piasecki GJ. Hy-poxia-induced sympathetic inhibition of the fetal plasma insulin response to hyperglycemia. Diabetes 42: 1621–1625, 1993.
35. Jones CT, Ritchie JW, Walker D. The effects of hypoxia on glucose turnover in the fetal sheep. J Dev Physiol 5: 223–235, 1983.
36. Jun J, Polotsky VY. Metabolic consequences of sleep-disordered breathing. ILAR J 50: 289–306, 2009.
37. Jun J, Polotsky VY. Sleep disordered breathing and metabolic effects: evidence from animal models. Sleep Med Clin 2: 263–277, 2007.
38. Jun J, Reinke C, Bedja D, Berkowitz D, Bevans-Fonti S, Li J, Barouch LA, Gabrielson K, Polotsky VY. Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 209: 381–386, 2010.
39. Jun JC, Drager LF, Najjar SS, Gottlieb SS, Brown CD, Smith PL, Schwartz AR, Polotsky VY. Effects of sleep apnea on nocturnal free fatty acids in subjects with heart failure. Sleep 34: 1207–1213, 2011.
40. Jun JC, Shin MK, Yao Q, Bevans-Fonti S, Poole J, Drager LF, Polotsky VY. Acute hypoxia induces hypertriglyceridemia by decreasing plasma triglyceride clearance in mice. Am J Physiol Endocrinol Metab 303: E377–E388, 2012.
41. Jun JC, Shin MK, Yao Q, Devera R, Fonti-Bevans S, Polotsky VY. Thermoneutrality modifies the impact of hypoxia on lipid metabolism. Am J Physiol Endocrinol Metab 304: E424–E435, 2013.
42. Karlsson S, Ahren B. Insulin and glucagon secretion in swimming mice: effects of autonomic receptor antagonism. Metabolism 39: 724–732, 1990.
43. Kuwahira I, Gonzalez NC, Heisler N, Piiper J. Changes in regional blood flow distribution and oxygen supply during hypoxia in conscious rats. J Appl Physiol 74: 211–214, 1993.
44. Lafontan M, Barbe P, Galitzky J, Tavernier G, Langin D, Carpene C, Bousquet-Melou A, Berlan M. Adrenergic regulation of adipocyte metabolism. Human Reprod 12, Suppl 1: 6–20, 1997.
45. Larsen JJ, Hansen JM, Olsen NV, Galbo H, Dela F. The effect of altitude hypoxia on glucose homeostasis in men. J Physiol 504: 241–249, 1997.
46. Lavie L. Obstructive sleep apnoea syndrome–an oxidative stress disorder. Sleep Med Rev 7: 35–51, 2003.
47. Lee EJ, Alonso LC, Stefanovski D, Strollo HC, Romano LC, Zou B, Singamsetty S, Yester KA, McGaffin KR, Garcia-Ocana A, O’Donnell CP. Time-dependent changes in glucose and insulin regulation during intermittent hypoxia and continuous hypoxia. Eur J Appl Physiol 113: 467–478, 2013.
48. Leuenberger UA, Hogeman CS, Quraishi SA, Linton-Frazier L, Gray KS. Short-term intermittent hypoxia enhances sympathetic responses to continuous hypoxia in humans. J Appl Physiol 103: 835–842, 2007.
49. Li J, Grigoryev DN, Ye SQ, Thorne L, Schwartz AR, Smith PL, O’Donnell CP, Polotsky VY. Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice. J Appl Physiol 99: 1643–1648, 2005.
50. Lodhi IJ, Semenkovich CF. Why we should put clothes on mice. Cell Metab 9: 111–112, 2009.
51. Lohmann FW, Loesment WA, Kaehler H. Beta-receptor blockade, physical activity, and metabolism. J Cardiovasc Pharmacol 16, Suppl 5: S45–S52, 1990.
52. Louis M, Punjabi NM. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol 106: 1538–1544, 2009.
53. Marshall NS, Wong KK, Phillips CL, Liu PY, Knuiman MW, Grunstein RR. Is sleep apnea an independent risk factor for prevalent and incident diabetes in the Busselton Health Study? J Clin Sleep Med 5: 15–20, 2009.
54. McElroy W. Hypoxia as a stimulus for free fatty acid mobilization in dogs. J Appl Physiol 16: 760–762, 1961.
55. McNicholas WT. Obstructive sleep apnea and inflammation. Prog Car-diovasc Dis 51: 392–399, 2009.
56. Nakao K, Miyata M. The influence of phentolamine, an adrenergic blocking agent, on insulin secretion during surgery. Eur J Clin Invest 7: 41–45, 1977.
57. Nannapaneni S, Ramar K, Surani S. Effect of obstructive sleep apnea on type 2 diabetes mellitus: a comprehensive literature review. World J Diabetes 4: 238–244, 2013.
58. Oltmanns KM, Gehring H, Rudolf S, Schultes B, Rook S, Schweiger U, Born J, Fehm HL, Peters A. Hypoxia causes glucose intolerance in humans. Am J Respir Crit Care Med 169: 1231–1237, 2004.
59. Pallayova M, Donic V, Tomori Z. Beneficial effects of severe sleep apnea therapy on nocturnal glucose control in persons with type 2 diabetes mellitus. Diabetes Res Clin Pract 81: e8–e11, 2008.
60. Papanas N, Steiropoulos P, Nena E, Tzouvelekis A, Maltezos E, Trakada G, Bouros D. HbA1c is associated with severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men. Vasc Health Risk Manag 5: 751–756, 2009.
61. Peltonen GL, Scalzo RL, Schweder MM, Larson DG, Luckasen GJ, Irwin D, Hamilton KL, Schroeder T, Bell C. Sympathetic inhibition attenuates hypoxia induced insulin resistance in healthy adult humans. J Physiol 590: 2801–2809, 2012.
62. Porta S, Hofmann HM, Ertl U, Rinner I, Puerstner P, Weiss PA, Felsner P, Korsatko W. Preventive action of phentolamine on adrenaline induced blood glucose elevation in humans. Acta Endocrinol 117: 166–172, 1988.
63. Porte D Jr, Robertson RP. Control of insulin secretion by cat-echolamines, stress, and the sympathetic nervous system. Fed Proc 32: 1792–1796, 1973.
64. Reichmuth KJ, Austin D, Skatrud JB, Young T. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 172: 1590–1595, 2005.
65. Reinke C, Bevans-Fonti S, Drager LF, Shin MK, Polotsky VY. Effects of different acute hypoxic regimens on tissue oxygen profiles and metabolic outcomes. J Appl Physiol 111: 881–890, 2011.
66. Rosell S. Release of free fatty acids from subcutaneous adipose tissue in dogs following sympathetic nerve stimulation. Acta Physiol Scand 67: 343–351, 1966.
67. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112: 2660–2667, 2005.
68. Shin MK, Han W, Bevans-Fonti S, Jun JC, Punjabi NM, Polotsky VY. The effect of adrenal medullectomy on metabolic responses to chronic intermittent hypoxia. Respir Physiol Neurobiol 203: 60–67, 2014.
69. Shpirer I, Rapoport MJ, Stav D, Elizur A. Normal and elevated HbA1C levels correlate with severity of hypoxemia in patients with obstructive sleep apnea and decrease following CPAP treatment. Sleep Breathing 16: 461–466, 2012.
70. Skoglund G, Lundquist I, Ahren B. Effects of alpha 1- and alpha 2-adrenoceptor stimulation and blockade on plasma insulin levels in the mouse. Pancreas 1: 415–420, 1986.
71. Snell K. Regulation of hepatic glucose metabolism by insulin and counter-regulatory hormones. Proc Nutr Soc 50: 567–575, 1991.
72. Somers VK, Abboud FM. Chemoreflexes–responses, interactions and implications for sleep apnea. Sleep 16: S30–S33, 1993.
73. Stamatakis K, Sanders MH, Caffo B, Resnick HE, Gottlieb DJ, Mehra R, Punjabi NM. Fasting glycemia in sleep disordered breathing: lowering the threshold on oxyhemoglobin desaturation. Sleep 31: 1018–1024, 2008.
74. Stickney JC, Northup DW, Van Liere EJ. Blood sugar and dextrose tolerance during anoxia in the dog. Am J Physiol 154: 423–427, 1948.
75. Tagaito Y, Polotsky VY, Campen MJ, Wilson JA, Balbir A, Smith PL, Schwartz AR, O’Donnell CP. A model of sleep-disordered breathing in the C57BL/6J mouse. J Appl Physiol 91: 2758–2766, 2001.
76. West SD, Nicoll DJ, Wallace TM, Matthews DR, Stradling JR. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 62: 969–974, 2007.
77. Yokoe T, Alonso LC, Romano LC, Rosa TC, O’Doherty RM, Garcia-Ocana A, Minoguchi K, O’Donnell CP. Intermittent hypoxia reverses the diurnal glucose rhythm and causes pancreatic beta-cell replication in mice. J Physiol 586: 899–911, 2008.
78. Young PM, Rose MS, Sutton JR, Green HJ, Cymerman A, Houston CS. Operation Everest II: plasma lipid and hormonal responses during a simulated ascent of Mt. Everest. J Appl Physiol 66: 1430–1435, 1989.